Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diluted lidocaine spray for pain reduction during burn debridement
IRCT20231126060194N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of lidocaine in burn injury and pain (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Pain. Started Dec 2023; status: completed.
02
Drugs
lidocaine
03
Conditions
burn injurypain
Beyond the preview
Go deeper on IRCT20231126060194N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231126060194N1.